LongCovid
“If you are high-risk, the answer is straightforward. If you are low-risk, there is less consensus.
Based on all of the recent findings, there is consensus that if you are at high risk, getting a vaccine booster at least annually, and possibly more frequently, continues to be valuable. For young, healthy people, though, the decision of when to get a booster, or whether to get one at all, is more individual.”
You can read this article published by the New York Times using the link below.
Upcoming workshop on Long COVID before the Special Committee on the COVID-19 pandemic (COVI) of the European Parliament in Brussels. The workshop will discuss key facts and developments related to long COVID,…
The San Diego Union-Tribune has recently published an editorial on the new Long COVID study by Dr. Ziyad Al-Alyand (Nature Medicine Journal). “The perception that the pandemic is…
“While in some cases participants with organ damage were no longer experiencing symptoms, organ impairment was associated with a higher likelihood of persistent symptoms and reduced function at…
A recent preprint found SARS-CoV-2 antigens in plasma up to 14 months post-COVID. Could these antigens have a causal role in Long Covid patients? Additional work will be needed to…